Medicare Enrolled
Dr. George Canellakis, M.D.
Urology Physician · North Andover, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Canellakis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Canellakis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Canellakis
Dr. George Canellakis is an urology physician in North Andover, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Canellakis performed 3,078 Medicare services across 1,942 unique beneficiaries.
Between the years covered by Open Payments, Dr. Canellakis received a total of $6,954 from 23 pharmaceutical and/or device companies across 109 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Canellakis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 32% volume in MA
$6,954 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,078
Medicare services
Top 32% in MA for urology physician
1,942
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~154 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
851 | $95 | $325 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
831 | $2 | $15 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
238 | $9 | $259 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
169 | $34 | $70 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
129 | $72 | $241 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
90 | $132 | $450 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
83 | $202 | $550 |
| Complicated insertion of bladder tube | 61 | $118 | $289 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
61 | $9 | $224 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
55 | $41 | $1,500 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
53 | $99 | $250 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
47 | $63 | $201 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
44 | $65 | $161 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
39 | $69 | $140 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
33 | $67 | $289 |
| BCG treatment for bladder cancer | 33 | $2 | $236 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
32 | $28 | $115 |
| Complicated change of bladder tube A complex surgical procedure to replace or modify a urinary diversion tube or conduit. This involves intricate manipulation of the urinary tract to ensure proper drainage and function. |
27 | $114 | $230 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
27 | $80 | $254 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
22 | $24 | $259 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
20 | $80 | $250 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
19 | $58 | $346 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
16 | $149 | $300 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
15 | $52 | $201 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
15 | $334 | $1,825 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $107 | $350 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
14 | $163 | $2,000 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
13 | $91 | $1,446 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
13 | $34 | $70 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
13 | $34 | $70 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
10.8% medium
88.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,954
Total received (2018-2024)
Avg $993/year across 7 years
Top 21% in MA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
109
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,286 (90.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$668 (9.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$758
2023
$633
2022
$416
2021
$412
2020
$172
2019
$1,399
2018
$3,166
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Ferring Pharmaceuticals Inc.
$176
Teleflex LLC
$172
ABBVIE INC.
$160
Astellas Pharma US Inc
$62
Merck Sharp & Dohme LLC
$34
ACCORD HEALTHCARE, INC.
$33
Janssen Biotech, Inc.
$29
Antares Pharma, Inc.
$29
Blue Earth Diagnostics Limited
$24
Novartis Pharmaceuticals Corporation
$22
PROGENICS PHARMACEUTICALS, INC.
$17
Top 3 companies account for 67.1% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$3,327
Teleflex LLC
$935
BOSTON SCIENTIFIC CORPORATION
$741
Coloplast Corp
$327
Astellas Pharma US Inc
$322
ABBVIE INC.
$259
Janssen Biotech, Inc.
$201
Ferring Pharmaceuticals Inc.
$176
AbbVie Inc.
$143
AngioDynamics, Inc.
$107
AbbVie, Inc.
$68
Merck Sharp & Dohme LLC
$56
Axonics, Inc.
$46
Endo Pharmaceuticals Inc.
$37
ACCORD HEALTHCARE, INC.
$33
Antares Pharma, Inc.
$29
Progenics Pharmaceuticals, Inc.
$26
Blue Earth Diagnostics Limited
$24
Metuchen Pharmaceuticals
$23
Novartis Pharmaceuticals Corporation
$22
KARL STORZ Endoscopy-America
$21
PROGENICS PHARMACEUTICALS, INC.
$17
Boston Scientific Corporation
$16
Top 3 companies account for 71.9% of all-time payments
Associated products mentioned in payments ›
24FR BIPLR COAG ELECTRDE · ADSTILADRIN · ALTIS · AMS · Axonics · BOTOX · Bulkamid · CAMCEVI · DIGITEX · ERLEADA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lupron · Myrbetriq · NANOKNIFE · PKG/6 · PLUVICTO · POSLUMA · PYLARIFY · STERILE · SpaceOAR VUE System - 10mL · Stendra · UROLIFT · UroLift · UroLift System · XIAFLEX · XTANDI · XYOSTED · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
176
Per 100K population
21.8
County median income
$99,431
Nearest hospital
HOLY FAMILY HOSPITAL
6.5 mi
6.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Canellakis is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Canellakis experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Canellakis performed 851 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Canellakis receive payments from pharmaceutical companies?
Yes. Dr. Canellakis received a total of $6,954 from 23 companies across 109 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Canellakis's costs compare to other urology physicians in North Andover?
Dr. Canellakis's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Canellakis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in North Andover
Browse urology physicians in North Andover ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MA
Which MA urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology